United Kingdom Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Published by: Global Markets Direct

Published: Mar. 27, 2009 - 106 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Definitions of Markets Covered in This Report

3.1 Drug delivery devices

3.2 Needle-free Injections

3.3 Inhalation Systems

3.3.1 Metered Dose Inhaler

3.3.2 Dry powder inhaler

3.4 Infusion Systems

3.4.1 Infusion pumps

3.4.2 Syringe pumps

3.4.3 Disposable Infusion sets

4 Healthcare Sector Review

4.1 Healthcare Expenditure

4.2 Healthcare Infrastructure

4.3 Healthcare Policy

4.4 United Kingdom Healthcare Trade Statistics

5 Regulation System

5.1 Medical Equipment Approval Process

5.1.1 Classification of Medical Devices

5.1.2 Conformity Assessment Process

5.1.2.1 Class I devices

5.1.2.2 Class IIa devices

5.1.2.3 Class IIb devices

5.1.2.4 Class III devices

5.2 Medical Device approval fee

5.3 Post Market Surveillance (PMS)

6 Pricing and Reimbursement

6.1 Market Pricing

6.2 Government Policies for Reimbursement

7 Distribution Structure

8 Drug Delivery Devices In United Kingdom

8.1 Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015

8.2 Drug Delivery Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015

8.3 Drug Delivery Devices, United Kingdom, Category Volume (Units), 2000-2015

8.4 Drug Delivery Devices, United Kingdom, Company Share (2006-2007)

9 Infusion Systems In United Kingdom

9.1 Infusion Systems Overall Revenue (2000-2015)

9.2 Infusion Systems Overall Volume (2000-2015)

9.3 Infusion Systems Average Price (2000-2015)

9.4 Infusion Systems Distribution Share (2007-2008)

9.5 Infusion Systems, United Kingdom, Company Share (2006-2007)

10 Inhalation Systems In United Kingdom

10.1 Inhalation Systems Overall Revenue (2000-2015)

10.2 Inhalation Systems Overall Volume (2000-2015)

10.3 Inhalation Systems Average Price (2000-2015)

10.4 Inhalation Systems Distribution Share (2007-2008)

10.5 Inhalation Systems, United Kingdom, Company Share (2006-2007)

11 Needle Free Injections In United Kingdom

11.1 Needle Free Injections Overall Revenue (2000-2015)

11.2 Needle Free Injections Overall Volume (2000-2015)

11.3 Needle Free Injections Average Price (2000-2015)

11.4 Needle Free Injections Distribution Share (2007-2008)

11.5 Needle Free Injections, United Kingdom, Company Share (2006-2007)

12 Overview of Key Companies in United Kingdom Drug Delivery Devices Market

12.1 AstraZeneca PLC Company Profile

12.1.1 Company Overview

12.2 Boehringer Ingelheim GmbH Company Profile

12.2.1 Company Overview

12.2.2 Value Chain Analysis

12.2.2.1 Manufacturing

12.2.2.2 Product Development

12.2.2.3 Sales and Marketing

12.3 GlaxoSmithKline plc Company Profile

12.3.1 Company Overview

12.4 Baxter International Inc. Company Profile

12.4.1 Company Overview

12.4.2 Value Chain Analysis

12.4.2.1 Manufacturing

12.4.2.2 Product Development

12.4.2.3 Sales and Marketing

12.5 Novartis AG

12.5.1 Company Overview

12.6 Cardinal Health, Inc. Company Profile

12.6.1 Company Overview

12.6.2 Value Chain Analysis

12.6.2.1 Manufacturing

12.6.2.2 Product Development

12.6.2.3 Sales and Marketing

12.7 Smiths Medical Company Profile

12.7.1 Company Overview

12.7.2 Value Chain Analysis

12.7.2.1 Manufacturing

12.7.2.2 Product Development

12.7.2.3 Sales and Marketing

12.8 Consort Medical plc Company Profile

12.8.1 Company Overview

12.8.2 Value Chain Analysis

12.8.2.1 Manufacturing

12.8.2.2 Product Development

12.8.2.3 Sales and Marketing

12.8.3 Consort Medical plc Pipeline Products

12.8.3.1 Consort Medical plc Pipeline Products By Equipment Type

12.8.3.2 Consort Medical plc Pipeline Products By Development Stage

12.8.3.3 Consort Medical plc Pipeline Products By Therapy Area

12.9 B. Braun Melsungen AG Company Profile

12.9.1 Company Overview

12.9.2 Value Chain Analysis

12.9.2.1 Manufacturing

12.9.2.2 Product Development

12.9.2.3 Research and Development

12.9.2.4 Sales and Marketing

12.10 Fresenius SE

12.10.1 Company Overview

12.11 Hospira, Inc. Company Profile

12.11.1 Company Overview

12.11.2 Value Chain Analysis

12.11.2.1 Manufacturing

12.11.2.2 Product Development

12.11.2.3 Research and Development

12.11.2.4 Sales and Marketing

12.11.3 Hospira, Inc. Pipeline Products

12.11.3.1 Hospira, Inc. Pipeline Products by Equipment Type

12.11.3.2 Hospira, Inc. Pipeline Products by Development Stage

12.11.3.3 Hospira, Inc. Pipeline Products by Therapy Area

12.12 Bioject Medical Technologies Inc.

12.12.1 Company Overview

12.12.2 Value Chain Analysis

12.12.2.1 Manufacturing

12.12.2.2 Product Development

12.12.2.3 Sales and Marketing

12.13 Owen Mumford Ltd. Company Profile

12.13.1 Company Overview

12.14 SkyePharma PLC Company Profile

12.14.1 Company Overview

13 Financial Deals Landscape

13.1 Acquisition

13.1.1 Evolutec To Acquire Nanoco Technologies In A Reverse Acquisition

13.1.2 Orexo To Acquire PharmaKodex

13.1.3 Mundipharma International Acquires Clinical Designs From Abingworth Management

13.1.4 Partnerships

13.1.4.1 MonoSol Rx Enters Into An Agreement With Midatech

14 Recent Developments

14.1 Strategy and Business Planning

14.1.1 Sep 02, 2008: Bespak Plans New GBP1 Million Lynn Facility

14.2 Product News

14.2.1 Feb 24, 2009: Bioject Medical Announces Collaborative Research Agreement With IAVI

15 Appendix

15.1 Global Markets Direct Research Methodology

15.2 Coverage

15.3 Secondary Research

15.4 Primary Research

15.5 Models

15.6 Forecasts

15.7 Expert Panel Validation

15.8 Currency Conversion

15.9 Contact Us

15.10 Disclaimer

Abstract

United Kingdom Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the UK Drug drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in UK

Scope

• The report provides drug delivery devices information broken down into detailed categories and segments in United kingdom.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the drug delivery devices market in United Kingdom.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.